VEGF is another hypoxia-responsive factor that is a key player in the development of tumor growth as it promotes angiogenesis, which is a prerequisite for tumor aggressiveness [28] and has been linked to poor prognosis, nodal metastasis, and low survival in head and neck squamous cell carcinoma [25,29]. This evidence concerns the gene VEGFA and neoplasm.